This type of collagen is released by a primary tumor in response to the hypoxic conditions in the tumor environment, where BMDCs degrade collagen type IV through the expression of MMP-2, which contributes to invasion and metastatic growth [330]. This evidence concerns the gene MMP2 and neoplasm.